pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-655 |
Genomic Coordinates | chr14: 101049550 - 101049646 |
Synonyms | MIRN655, hsa-mir-655, MIR655 |
Description | Homo sapiens miR-655 stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Associated Diseases | ![]() |
Mature miRNA Information | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-655-5p | ||||||||||||||||||||||||||||||
Sequence | 23| AGAGGUUAUCCGUGUUAUGUUC |44 | ||||||||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||||||||
Experiments | Illumina | ||||||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||||
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | SEC24A | ||||||||||||||||||||
Synonyms | - | ||||||||||||||||||||
Description | SEC24 homolog A, COPII coat complex component | ||||||||||||||||||||
Transcript | NM_021982 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on SEC24A | |||||||||||||||||||||
3'UTR of SEC24A (miRNA target sites are highlighted) |
>SEC24A|NM_021982|3'UTR 1 ATGAATGAAGAAATTTGACTTATTTTTAAGGAATGTCACGATAGTGCAGAATACCTGGAAATGTGTAATACCTTCTTTTT 81 CTATTATGTTTGTGGACTAATGTGATGATTGAGATGTTCTCACTGTGATTTCAACAACCTATAGCAAATAAAAGACCACA 161 GCAGAGAATCAAACATGCAACTCTGAAATACTGTATTTTTCAAATCAGAATATAGCTACGTATGATTGGATACTTTTTTC 241 TTGCCAATTATGTTTGAGTTGTTATGGATTAAAATAAGAATATTGCAGAGGCAAAGTACATTTTGTAAAATAAAGATTTC 321 TGTGTTCTACATGTATATTTCTCATTTTTAATTTTTCTGAATCTTTGGCTGCTACATTTAAAACCTCACAAACCTAAGTG 401 TTGCAGGGAAGTTACAAATTGATTGGTAGTGATGTTTTTAAAATAAAAACAATGGAAAGTAAATATAATGTAGGAAAACT 481 AGAATTCATTCCCCACACGTGTCTTTTTTTTTTCTTTGTTAAGGGAAAGGATCATGTTGACTAAAACTAAACTAATTCTA 561 GTATAGCTTGAGAAAAATATGAAGAAACACATTCAAGCTTTAAAATCTGTCAGTATTCTTTATGCTTGAAGAACAAAGTC 641 ACTTTGATTTGAAGTGAGAACTATCATTAGGTGGTTTTCTGATTTCCTGATGAAGAGTTGGACATACTGTCTTAATCTAT 721 AGTGAAAAGAATTTGAGCTGTCTTCATAAACACTGGGACTAGCAATGATAATAGGGAGATAAGAAACTTTAATTATCTTG 801 ATCCTTTAAGTGGATTTTATTTGGTGCATTTCTGCTCTGGGTATATAATAAAAGTGGGGGTTTTTGGTGAAATGAGTGAA 881 GAAATGAAAGGTTTCTAAAGTGCTATCCAAATACATCAGTAACATTTTTCTAAGGAGTTTAATTGTTAAATTGGAAGTCA 961 TTCATAAGAAATATTTATGCTTGAATATGAAAATCTATGAAAGCATAAATGCTGCTGTTTGATTTGGTGGATATTAAGAT 1041 TATACACATCCAACATATTAAAGTTATGAAAGAAACTTGACTTCTGAAAATCCTTAAGAGACTGCTTTCTTGATTCAGCT 1121 AGAGAAATATTATAGTCAAAACTATTGAGTGAATTTTGTTTACAAATAGGTAAATTATACATTTGTATATTTAAAGTGCT 1201 GTGACATAGTATCTTTAAGAGTTTGGCTCAGTTTTCACAGATTCATTTTGTCTTAAGAATTTCTTAAATATGTTCATGTA 1281 TAATACTTGATCAAAATATTTTTGGGTTTTTTGTTTTGTTTTAATGGGTTAGAAAATGTTTACAATCTTGGTCTTATATG 1361 ATCACCAATGGAATAGTAACTTCCAGGTTTATATCAATATGAGCTGACTTTAACTGAGTTGTTTGGGATAGGGAAGAAGC 1441 AGTCCCTCTACAGTATACAACTACTGCTTGCCAGCTGGATCAAAATAATCATGTTTTATGAAAATATCTCCCTTAAGCAG 1521 TGTTAAGGTTGGTTTGCAGTGTGTAAGTGGCACATTGAACTGGAAGTTTTCTTGAAAGCTGCTTCATCTATTAAGAAGCA 1601 ATTTTCAAATTGTAGCGAATTATATTATCCCCTCTTTTAAAGAAACAGTCGTTATATGCTGATGTTTCTTAAAATAACTA 1681 AAATGTTCCTCTTAATGTGATTTTAAATGGAGTTATTTGTAGGTCCTTTCTTAGTAGTAAAGAATCTTCTAGAGGGAAAC 1761 ATTTGTGCTTTTAGGGATAATCTTCCTTGTGCCTCACTACATCCCTAAGTGGGTATGACTCTTGTTATTACCACATGCTT 1841 TTTTAGTATATTTCACAAATTTACTTTTAAATATTATTTTAGATACGGTGTAACATGTGCAATTCAGAATAATTTTATAA 1921 CAGGTCATGAAAAACATAACTTTAGTTAGGATTCACAATATTTGTTCTCCACATAATGAGAGAATGAATGAGCCTTTGGA 2001 GATACTGATATAAGGCAATTATTTTTTGCAATGTTGAATGTGTTTTTTAGTTTGATTCTTTTTTTTTCCCCCAATAGGGC 2081 ACTACCTGCCATATCATCTTGTATTACTTTTTGATGTAAAGCGACTAATATTTACACTATGCCATATTTTTTTTAATTAT 2161 AGTTGTAAATTATGAAAGATCCTTGAATTTTCTACAGATCTACAACTACTAATGTAACAGACAAGGGCAATCTTGGTATT 2241 TAAATCTGAGCATGGCAGTTCTACCATAAAAAGTACTCTATTTTTCTAATTTCTAGGATTTTTAAAATAACATTTCTGTA 2321 AGTCTGACATACTAATAGTCACTCAAGCAGTACCATTTATTTTAGTTTGCATATATTTTCACTGTTTTTAATTTAATGTA 2401 TTGAGTCTAATAGACTGTTTTGCAATAATTAGAATAAAGATTTATTTCTTCTAATCAAAGATGCATAACAGCTATTATCT 2481 AGGGGACCACCAAATGTGATTTCAAAATTTTGTTAACTATTACAAATGTAATCCTTATATAGAAATTTTAATTTTGTAAA 2561 GTAGTGTATAATATTGTAATATTAAATTCTTGTTCTTAAATTCAAATATGTATTGATCTTCAATGTGCTGTGTTAAATCT 2641 TGCTTCTCTGAAAAGTTGGAGACAAGATTTGTCTTCCTTTTTACAGTTTGTAATTTTCACTGTTTTATTCCTGTTAAAAA 2721 AAAAAAAAAGTCATTTGTAACCCATGCAGACCATTGTTTGATCTATGCTAACTTATCAACTTGGCTATTCAATAAAGTTA 2801 ATTGAAAAGAGCTTATAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Disease | 10802.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714644. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | TZM-bl | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM714644 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repA |
Location of target site | ENST00000398844.2 | 3UTR | AAUCUUUGGCUGCUACAUUUAAAACCUCACAAACCUAAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000398844.2 | 3UTR | AAUCUUUGGCUGCUACAUUUAAAACCUCACAAACCUAAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
91 hsa-miR-655-5p Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT080691 | KIAA1468 | KIAA1468 | ![]() |
![]() |
2 | 2 | ||||||
MIRT095086 | SEC24A | SEC24 homolog A, COPII coat complex component | ![]() |
![]() |
2 | 4 | ||||||
MIRT122450 | SMIM13 | small integral membrane protein 13 | ![]() |
![]() |
2 | 2 | ||||||
MIRT214635 | SMAD5 | SMAD family member 5 | ![]() |
![]() |
2 | 4 | ||||||
MIRT268267 | CCND1 | cyclin D1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT312418 | GRPEL2 | GrpE like 2, mitochondrial | ![]() |
![]() |
2 | 2 | ||||||
MIRT329008 | DSTN | destrin, actin depolymerizing factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT329824 | PDCD4 | programmed cell death 4 | ![]() |
![]() |
2 | 4 | ||||||
MIRT389635 | LRRC58 | leucine rich repeat containing 58 | ![]() |
![]() |
2 | 6 | ||||||
MIRT443969 | FAM198B | family with sequence similarity 198 member B | ![]() |
![]() |
2 | 2 | ||||||
MIRT444080 | C12orf73 | chromosome 12 open reading frame 73 | ![]() |
![]() |
2 | 2 | ||||||
MIRT444886 | TMEM196 | transmembrane protein 196 | ![]() |
![]() |
2 | 2 | ||||||
MIRT445506 | CRNKL1 | crooked neck pre-mRNA splicing factor 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT446292 | ACSL3 | acyl-CoA synthetase long chain family member 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT446462 | THAP1 | THAP domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT446472 | THUMPD3 | THUMP domain containing 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT447413 | MED21 | mediator complex subunit 21 | ![]() |
![]() |
2 | 2 | ||||||
MIRT447491 | KIAA1715 | lunapark, ER junction formation factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT448965 | CDADC1 | cytidine and dCMP deaminase domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT449602 | INIP | INTS3 and NABP interacting protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT449607 | PRPF4 | pre-mRNA processing factor 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT449737 | TAB2 | TGF-beta activated kinase 1/MAP3K7 binding protein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT451668 | KRT8 | keratin 8 | ![]() |
![]() |
2 | 4 | ||||||
MIRT452424 | QDPR | quinoid dihydropteridine reductase | ![]() |
![]() |
2 | 2 | ||||||
MIRT455187 | AGTRAP | angiotensin II receptor associated protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT456059 | SLC25A28 | solute carrier family 25 member 28 | ![]() |
![]() |
2 | 2 | ||||||
MIRT456488 | SERAC1 | serine active site containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT456631 | ARMCX6 | armadillo repeat containing, X-linked 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT459621 | SLC25A33 | solute carrier family 25 member 33 | ![]() |
![]() |
2 | 2 | ||||||
MIRT461162 | SLC11A2 | solute carrier family 11 member 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT461990 | PACSIN1 | protein kinase C and casein kinase substrate in neurons 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT463149 | ZNF385A | zinc finger protein 385A | ![]() |
![]() |
2 | 4 | ||||||
MIRT463465 | ZC3HAV1L | zinc finger CCCH-type containing, antiviral 1 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT463801 | XPOT | exportin for tRNA | ![]() |
![]() |
2 | 2 | ||||||
MIRT464010 | WDR26 | WD repeat domain 26 | ![]() |
![]() |
2 | 2 | ||||||
MIRT465302 | TRIB1 | tribbles pseudokinase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT468837 | RRM2 | ribonucleotide reductase regulatory subunit M2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT469132 | RNF126 | ring finger protein 126 | ![]() |
![]() |
2 | 2 | ||||||
MIRT469244 | RHOB | ras homolog family member B | ![]() |
![]() |
2 | 2 | ||||||
MIRT472414 | NCKAP1 | NCK associated protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT472432 | NCBP2 | nuclear cap binding protein subunit 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT472808 | MTMR12 | myotubularin related protein 12 | ![]() |
![]() |
2 | 2 | ||||||
MIRT477893 | DVL3 | dishevelled segment polarity protein 3 | ![]() |
![]() |
2 | 4 | ||||||
MIRT477963 | DPM2 | dolichyl-phosphate mannosyltransferase subunit 2, regulatory | ![]() |
![]() |
2 | 2 | ||||||
MIRT479258 | CHSY1 | chondroitin sulfate synthase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT479718 | CCNF | cyclin F | ![]() |
![]() |
2 | 2 | ||||||
MIRT480231 | C9orf41 | carnosine N-methyltransferase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT482600 | ABHD14B | abhydrolase domain containing 14B | ![]() |
![]() |
2 | 2 | ||||||
MIRT483096 | TFPI | tissue factor pathway inhibitor | ![]() |
![]() |
2 | 2 | ||||||
MIRT484644 | TBC1D5 | TBC1 domain family member 5 | ![]() |
![]() |
2 | 4 | ||||||
MIRT488899 | CLDND1 | claudin domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT491954 | VPS52 | VPS52, GARP complex subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT496937 | LBR | lamin B receptor | ![]() |
![]() |
2 | 2 | ||||||
MIRT498546 | TMEM30B | transmembrane protein 30B | ![]() |
![]() |
2 | 2 | ||||||
MIRT501778 | NRBF2 | nuclear receptor binding factor 2 | ![]() |
![]() |
2 | 6 | ||||||
MIRT516286 | DBT | dihydrolipoamide branched chain transacylase E2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT516351 | GABPB1 | GA binding protein transcription factor beta subunit 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT516751 | ZNF100 | zinc finger protein 100 | ![]() |
![]() |
2 | 2 | ||||||
MIRT517939 | ZNF431 | zinc finger protein 431 | ![]() |
![]() |
2 | 4 | ||||||
MIRT518295 | ZNF514 | zinc finger protein 514 | ![]() |
![]() |
2 | 4 | ||||||
MIRT518515 | CASP10 | caspase 10 | ![]() |
![]() |
2 | 2 | ||||||
MIRT519017 | NOA1 | nitric oxide associated 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT519171 | SCO1 | SCO1, cytochrome c oxidase assembly protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT519470 | SPTLC2 | serine palmitoyltransferase long chain base subunit 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT521029 | SLC30A5 | solute carrier family 30 member 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT521251 | SAMD8 | sterile alpha motif domain containing 8 | ![]() |
![]() |
2 | 2 | ||||||
MIRT521682 | PRKAR2A | protein kinase cAMP-dependent type II regulatory subunit alpha | ![]() |
![]() |
2 | 2 | ||||||
MIRT529386 | SKP1 | S-phase kinase associated protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT545507 | NAP1L1 | nucleosome assembly protein 1 like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT549655 | RSL1D1 | ribosomal L1 domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT551041 | CTSB | cathepsin B | ![]() |
![]() |
2 | 4 | ||||||
MIRT551441 | ZNF490 | zinc finger protein 490 | ![]() |
![]() |
2 | 4 | ||||||
MIRT554778 | RHEBP1 | RHEB pseudogene 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT565793 | SEC14L5 | SEC14 like lipid binding 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT566727 | MSL2 | MSL complex subunit 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT574668 | HNRNPDL | heterogeneous nuclear ribonucleoprotein D like | ![]() |
![]() |
2 | 2 | ||||||
MIRT610128 | DENND5B | DENN domain containing 5B | ![]() |
![]() |
2 | 2 | ||||||
MIRT624919 | FBXW2 | F-box and WD repeat domain containing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT641830 | TRIM71 | tripartite motif containing 71 | ![]() |
![]() |
2 | 2 | ||||||
MIRT662165 | IFNAR2 | interferon alpha and beta receptor subunit 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT667150 | NRXN3 | neurexin 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT689085 | ADNP2 | ADNP homeobox 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT696322 | DCAF15 | DDB1 and CUL4 associated factor 15 | ![]() |
![]() |
2 | 2 | ||||||
MIRT699062 | SNX4 | sorting nexin 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT703229 | GOLGA1 | golgin A1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT705743 | AMD1 | adenosylmethionine decarboxylase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT706087 | HNRNPU | heterogeneous nuclear ribonucleoprotein U | ![]() |
![]() |
2 | 2 | ||||||
MIRT709288 | MAPK8IP2 | mitogen-activated protein kinase 8 interacting protein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT711457 | RNF145 | ring finger protein 145 | ![]() |
![]() |
2 | 2 | ||||||
MIRT714708 | PPP3CC | protein phosphatase 3 catalytic subunit gamma | ![]() |
![]() |
2 | 2 | ||||||
MIRT719871 | CYP4F11 | cytochrome P450 family 4 subfamily F member 11 | ![]() |
![]() |
2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|